THE USE OF FIBRINOLYSIN IN THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME.
D035843:Biomedical Research; D001724:Birth Weight; D002585:Cesarean Section; D036861:Delivery, Obstetric; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D005260:Female; D005341:Fibrinolysin; D006801:Humans; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D010288:Parenteral Nutrition; D011247:Pregnancy; D012127:Respiratory Distress Syndrome, Newborn; D013299:Streptodornase and Streptokinase; D013300:Streptokinase
D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D005341:Fibrinolysin
BIRTH WEIGHT; CESAREAN SECTION; CLINICAL RESEARCH; DELIVERY; DRUG THERAPY; FIBRINOLYSIN; INFANT, NEWBORN; INFUSIONS, PARENTERAL; PARENTERAL FEEDING; RESPIRATORY DISTRESS SYNDROME; STREPTODORNASE AND STREPTOKINASE